BIIO

Bionovate Technologies Corp. [BIIO] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

BIIO Stock Summary

In the News

06:23 29 Mar 2024 BIIO

Bionovate applies to list on NASDAQ

CHAM, Switzerland, May 03, 2021 (GLOBE NEWSWIRE) -- Bionovate Technologies Corp., traded on OTC Markets (OTCPK:BIIO), announced that it has submitted a formal application to list its common shares (“Shares”) on the NASDAQ Stock Exchange (“NASDAQ”). NASDAQ is the second largest exchange by market capitalization worldwide and is home to many of the world's best technology companies.

10:29 29 Mar 2024 BIIO

Bionovate announces to reduce shares

CHAM, Switzerland, April 30, 2021 (GLOBE NEWSWIRE) -- Bionovate Technologies Corp., traded on OTC Markets (OTCPK:BIIO), announces the cancellation and return to treasury of 25,000,000 common shares of the company's stock. The stock transactions will soon be represented in reports filed with the United States Securities and Exchange Commission (“SEC”).

05:12 29 Mar 2024 BIIO

Bionovate Technologies Stock Is Estimated To Be

The stock of Bionovate Technologies (OTCPK:BIIO, 30-year Financials) shows every sign of being , according to GuruFocus Value calculation. GuruFocus Value is GuruFocus' estimate of the fair value at which the stock should be traded.

01:29 29 Mar 2024 BIIO

Bionovate Supports Startups in the Digital Health Markets

CHAM, Switzerland, March 04, 2021 (GLOBE NEWSWIRE) -- Bionovate Technologies Corp (OTCMKT: BIIO) (“Bionovate”), is currently in the process of compiling a shortlist for potential investments in start-ups in the digital healthcare markets, as announced. The COVID-19 pandemic has accelerated the digital transformation of the healthcare market and launched numerous innovative start-ups.

10:14 29 Mar 2024 BIIO

Bionovate Announces Return of Shares to Treasury

CHAM, Switzerland, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Bionovate Technologies Corp., traded on the Nasdaq OTC (OTCPK:BIIO), announces the cancellation and return to treasury of 13,820,000 common shares of the company's stock. The stock transactions will soon be represented in reports filed with the United States Securities and Exchange Commission (“SEC”).

09:15 29 Mar 2024 BIIO

Bionovate seeks to invest in Health and Life Care Startups

CHAM, Switzerland, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Bionovate Technologies Corp., traded on the Nasdaq OTC (OTCPK:BIIO), plans to strategically invest in startups in Europe in the health and life care sector and focus its investments strategy towards on-demand healthcare services. The company is in the process of building a shortlist of startups which have the potential of disrupting their respective industry.

09:45 29 Mar 2024 BIIO

Bionovate realigns its strategy: from Quantify Yourself to Know Yourself

CHAM, Switzerland, Nov. 27, 2020 (GLOBE NEWSWIRE) -- The medical device company Bionovate Technologies Corp adopts a strategic reorientation under new management. Aleksandar Vucak will realign the company as CEO after taking over the majority of the shares of the company, traded on the Nasdaq OTC (OTCPK:BIIO). 

BIIO Financial details

Company Rating
-
Market Cap
775
Income
0
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
-0.03
Forward P/E
-
PEG
-
P/S
-
P/B
-0.01
P/C
-
P/FCF
-3.28
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
37%
ROC
0.09%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
7.75M
Shs Float
3.95M
-
-
-
-
Target Price
-
52W Range
1.0E-4-1.0E-4
52W High
-
52W Low
-
RSI
54.26
Rel Volume
-
Avg Volume
333
Volume
Perf Week
0%
Perf Month
-
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
2.335
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.0001
Change
0%

BIIO Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-06-30

Metric History 2019-06-302020-06-302021-06-302022-06-30 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-1.34-0.01000
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
00000
Book value per share
-2.13-0.02-0.0100
Tangible book value per share
-2.13-0.02-0.0100
Share holders equity per share
-2.13-0.02-0.0100
Interest debt per share
2.420.010.0100
Market cap
1.07M25M42.84M00
Enterprise value
1.3M25.18M43.08M00
P/E ratio
-5.14-118.39-255.7900
Price to sales ratio
00000
POCF ratio
-3.68K245.06K-181.53K00
PFCF ratio
-3.68K245.06K-181.53K00
P/B Ratio
-3.24-63.01-85.1300
PTB ratio
-3.24-63.01-85.1300
EV to sales
00000
Enterprise value over EBITDA
-22.99-761.79-949.4600
EV to operating cash flow
-4.45K246.87K-182.53K00
EV to free cash flow
-4.45K246.87K-182.53K00
Earnings yield
-0.19-0.01000
Free cash flow yield
00000
Debt to equity
-0.68-0.47-0.4700
Debt to assets
00000
Net debt to EBITDA
-3.97-5.61-5.2300
Current ratio
00000
Interest coverage
-0.37-0.37-0.7400
Income quality
00000
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
8.030.050.0300
ROIC
0.530.270.2700
Return on tangible assets
00000
Graham Net
-2.13-0.02-0.0100
Working capital
-332.29K-396.67K-503.21K00
Tangible asset value
-332.29K-396.67K-503.21K00
Net current asset value
-332.29K-396.67K-503.21K00
Invested capital
-0.68-0.47-0.4700
Average receivables
00000
Average payables
74.05K66.65K28.83K15.98K0
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
0.630.530.3300
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q1

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
00000
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
00000
Book value per share
00000
Tangible book value per share
00000
Share holders equity per share
00000
Interest debt per share
00000
Market cap
00000
Enterprise value
00000
P/E ratio
00000
Price to sales ratio
00000
POCF ratio
00000
PFCF ratio
00000
P/B Ratio
00000
PTB ratio
00000
EV to sales
00000
Enterprise value over EBITDA
00000
EV to operating cash flow
00000
EV to free cash flow
00000
Earnings yield
00000
Free cash flow yield
00000
Debt to equity
00000
Debt to assets
00000
Net debt to EBITDA
00000
Current ratio
00000
Interest coverage
00000
Income quality
00000
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
00000
ROIC
00000
Return on tangible assets
00000
Graham Net
00000
Working capital
00000
Tangible asset value
00000
Net current asset value
00000
Invested capital
00000
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
00000
Capex per share
00000

BIIO Frequently Asked Questions

What is Bionovate Technologies Corp. stock symbol ?

Bionovate Technologies Corp. is a CH stock and trading under the symbol BIIO

What is Bionovate Technologies Corp. stock quote today ?

Bionovate Technologies Corp. stock price is $0.0001 today.

Is Bionovate Technologies Corp. stock public?

Yes, Bionovate Technologies Corp. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Similar Market Cap